Literature DB >> 11742153

Treatment of locally recurrent rectal cancer.

J Garcia-Aguilar1, J W Cromwell, C Marra, S H Lee, R D Madoff, D A Rothenberger.   

Abstract

PURPOSE: This study was designed to analyze the outcome for patients with isolated local recurrence after radical treatment of rectal cancer and to identify predictors of curative resection.
METHODS: The medical records of 87 patients who developed isolated local recurrence after curative radical surgery for primary rectal cancer were retrospectively reviewed. Survival rates from the time of recurrence were calculated using the Kaplan-Meier method. Tumor stage and histology, patient characteristics, and treatment variables were analyzed using logistic regression to identify predictors of curative surgery.
RESULTS: Symptomatic treatment alone or chemotherapy and/or radiation therapy was provided to 23 patients (26 percent), and surgical exploration was performed in 64 patients. In 22 patients (25 percent), the tumor was considered unresectable at surgery (n = 13) or was resected for palliation with gross or microscopic positive margins (n = 9). In 42 patients (48 percent), curative-intent resection was performed. The only independent predictors of resectability were younger age at diagnosis, earlier stage of the primary tumor, and initial treatment by sphincter-saving procedure. There was no difference in survival between patients who had no surgery and those who had palliative surgery. The estimated five-year survival rate for patients who had curative-intent resection was better than for those who had no surgery or palliative surgery (35 vs. 7 percent; P = 0.01). Of the 42 patients who underwent curative-intent resection, 14 (33 percent) developed a second recurrence at a mean of 15 +/- 11 months after reoperation. Twenty-five percent of patients developed major complications.
CONCLUSIONS: Salvage surgery for locally recurrent rectal cancer may be helpful in a selected group of patients. The stage and treatment of the primary tumor may help to identify patients with the best chance for curative-intent resection.

Entities:  

Mesh:

Year:  2001        PMID: 11742153     DOI: 10.1007/bf02234449

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  23 in total

Review 1.  Preoperative chemoradiation for rectal cancer: kudos and a caution.

Authors:  Wayne S Kendal; Hartley S Stern
Journal:  Can J Surg       Date:  2004-04       Impact factor: 2.089

2.  Clinical implication of additional selective lateral lymph node excision in patients with locally advanced rectal cancer who underwent preoperative chemoradiotherapy.

Authors:  Seok-Byung Lim; Chang Sik Yu; Chan Wook Kim; Yong Sik Yoon; Seong Ho Park; Tae Won Kim; Jong Hoon Kim; Jin Cheon Kim
Journal:  Int J Colorectal Dis       Date:  2013-08-14       Impact factor: 2.571

3.  Can the chemotherapeutic agents perform anticancer activity through miRNA expression regulation? Proposing a new hypothesis [corrected].

Authors:  Chiranjib Chakraborty; C George Priya Doss; Renu Sarin; Minna J Hsu; Govindasamy Agoramoorthy
Journal:  Protoplasma       Date:  2015-02-20       Impact factor: 3.356

4.  Curative potential of multimodality therapy for locally recurrent rectal cancer.

Authors:  Dieter Hahnloser; Heidi Nelson; Leonard L Gunderson; Imran Hassan; Michael G Haddock; Michael J O'Connell; Stephen Cha; Daniel J Sargent; Alan Horgan
Journal:  Ann Surg       Date:  2003-04       Impact factor: 12.969

5.  Selective lateral pelvic lymph node dissection: a comparative study of the robotic versus laparoscopic approach.

Authors:  Hye Jin Kim; Gyu-Seog Choi; Jun Seok Park; Soo Yeun Park; Hee Jae Lee; In Taek Woo; In Kyu Park
Journal:  Surg Endosc       Date:  2017-11-09       Impact factor: 4.584

Review 6.  Management of stage IV rectal cancer: palliative options.

Authors:  Sean M Ronnekleiv-Kelly; Gregory D Kennedy
Journal:  World J Gastroenterol       Date:  2011-02-21       Impact factor: 5.742

7.  Patterns and prognosis of locally recurrent rectal cancer following multidisciplinary treatment.

Authors:  Jun Zhao; Chang-Zheng Du; Ying-Shi Sun; Jin Gu
Journal:  World J Gastroenterol       Date:  2012-12-21       Impact factor: 5.742

8.  Predictors of successful salvage surgery for local pelvic recurrence of rectosigmoid colon and rectal cancers.

Authors:  Akihiko Kobayashi; Masanori Sugito; Masaaki Ito; Norio Saito
Journal:  Surg Today       Date:  2007-09-26       Impact factor: 2.549

9.  Prognostic factors affecting oncologic outcomes in patients with locally recurrent rectal cancer: impact of patterns of pelvic recurrence on curative resection.

Authors:  Jea-Kun Park; Young-Wan Kim; Hyuk Hur; Nam-Kyu Kim; Byung-Soh Min; Seung-Kook Sohn; Young-Deuk Choi; Young-Tae Kim; Jung-Bai Ahn; Jae-Kyung Roh; Ki-Chang Keum; Jin-Sil Seong
Journal:  Langenbecks Arch Surg       Date:  2008-07-29       Impact factor: 3.445

Review 10.  Detection and management of extrahepatic colorectal cancer in patients with resectable liver metastases.

Authors:  Yolanda Y L Yang; James W Fleshman; Steven M Strasberg
Journal:  J Gastrointest Surg       Date:  2007-07       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.